| Application | Recommended Dilution |
|---|---|
| WB | 1:500-1:2000 |
| IHC | 1:50-1:200 |
| FC | 1:50-1:200 |
HAT1, also known as histone acetyltransferase 1 or KAT1, serves as the catalytic subunit of the type B histone acetyltransferase complex, playing a fundamental role in chromatin assembly and epigenetic regulation. This enzyme acetylates newly synthesized histone H4 at lysines 5 and 12, a modification essential for proper histone deposition onto nascent DNA during replication. Given its involvement in cell cycle progression and chromatin dynamics, HAT1 has become an important target for researchers investigating epigenetic mechanisms, cancer biology, and cellular proliferation.
This recombinant monoclonal antibody, generated in rabbit against a synthetic peptide derived from human HAT1, offers the consistency and reliability that demanding experimental workflows require. As a sequence-defined recombinant clone, it eliminates the lot-to-lot variability that can compromise longitudinal studies, ensuring reproducible results across experiments conducted months or years apart.
Validation studies demonstrate robust performance across multiple applications. Western blot analysis detects a clean band at the predicted 50 kDa molecular weight across an extensive panel of human cell lines including Jurkat, HEK293, A-431, MCF-7, HeLa, PC-3, HepG2, and THP-1, as well as mouse NIH/3T3 cells, confirming cross-species reactivity with both human and mouse samples. Immunohistochemistry staining in paraffin-embedded human stomach tissue reveals specific nuclear localization consistent with HAT1's chromatin-associated function. Flow cytometry analysis in HepG2 cells shows clear positive signal separation from isotype controls, enabling quantitative assessment of HAT1 expression at the single-cell level.
This antibody supports research into histone modification pathways, DNA replication-coupled chromatin assembly, and epigenetic dysregulation in disease states.
Email: support@cusabio.com
Distributors Worldwide